The top-ranked countries in Intensity are Denmark, the United States, and Australia.
The scorecard uses a combination of absolute and relative metrics. While some metrics, such as productivity, are measured in absolute terms, the Intensity category uses relative metrics to account for each country's population and economy size.
Because of the use of relative metrics, the Intensity category allows you to compare large countries to each other, and it also identifies small countries with strong biotechnology activities.
The Intensity metrics also focus on inputs. Accordingly, countries that rank highly in this category may represent ideal locations for research facilities, or to look for partners.
The chart below shows the country scores for Intensity, ordered by rank and alphabetically by country name. Scroll down to the Intensity metrics for highlights of top performers in each metric.
Scores in these individual metrics are averaged to produce the overall category score shown above
The top-ranked countries in Publicly-traded company employees / capita are Denmark, Australia, and the United States.
The top-ranked countries in Publicly-traded company revenues / GDP are Denmark, the United States, and Australia.
The top-ranked countries in Biotechnology patents / total patents are Denmark, New Zealand, Australia, Belgium, and Singapore.
The top-ranked countries in Value added of knowledge- and technology-intensive are the United States, and Japan.
The top-ranked countries in Business expenditures on biotechnology R&D are the United States, France, and Switzerland.
Copyright © 2024 thinkBiotech LLC. Source data from Scientific American Worldview
Copyright 2024 thinkBiotech LLC